Hou YC, Chiu WC, Yeh CL, Yeh SL. Glutamine modulates lipopolysaccharide-induced activation of NF-B via the Akt/ mTOR pathway in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 302: L174 -L183, 2012. First published October 14, 2011 doi:10.1152/ajplung.00066.2011.-Lung epithelial cells are important barriers in the respiratory system that provoke inflammatory responses through nuclear factor (NF)-B activation to prevent pathogens from invading the body. Lipopolysaccharide (LPS) is a common pathogen-associated stimulus that activates IB kinase (IKK) to regulate NF-B-mediated inflammation through modulating nuclear translocation and phosphorylation of NF-B. Previously, it was shown that Akt and the mammalian target of rapamycin (mTOR) are involved in the phosphorylation of IKK to activate NF-B. Herein, we demonstrate that glutamine (GLN) modulated LPS-induced activation of NF-B through the Akt/mTOR/IKK pathway in BEAS-2B cells. BEAS-2B cells in submerged culture were placed in medium containing different concentrations of GLN (0, 0.5, 1, and 2.5 mM) with 1 g/ml LPS. Results showed that GLN deprivation induced phosphorylation of Akt/mTOR/IKK signaling, increased levels of NF-B nuclear translocation and phosphorylated NF-B, and upregulated NF-B-dependent transcriptional activity, which was suppressed by GLN administration. Expressions of NF-B-targeted genes were also reduced by supplemental GLN. GLN administration improved cell viability, whereas 0.5 mM GLN had a greater extent of inhibition on the Akt/mTOR/IKK/NF-B signaling cascade. The inhibitory effects of GLN on NF-B activation were also observed in cells cultured under air-liquid interface condition. These results indicate that GLN deprivation increased LPS-induced NF-B activation and transcriptional activity, which was reversed by GLN administration. The findings provide potential mechanisms of GLN's modulation of LPSinduced NF-B activation in lung epithelial cells and imply that maintaining a physiological concentration of GLN is essential in preventing LPS-induced lung inflammation. mammalian target of rapamycin; nuclear factor-B; BEAS-2B
mammalian target of rapamycin; nuclear factor-B; BEAS-2B THE LUNG EPITHELIUM, AN IMPORTANT interface with the environment, is constantly exposed to inhaled particles and pathogens. To prevent invasion by pathogens, epithelial cells lining the respiratory track represent a major barrier of the innate host defense and provoke inflammatory responses in the presence of microorganisms (8) . Bacterial infections are common causes of airway inflammation. Lipopolysaccharide (LPS) released from gram-negative bacteria is a potent proinflammatory pathogenassociated molecule, which interacts with Toll-like receptor (TLR)4 and activates nuclear factor (NF)-B to produce inflammatory cytokines and CXC chemokines for neutrophil attraction in bronchial epithelial cells (11) .
NF-B is retained in the cytoplasm in an inactive state by being bound to IB␣. Upon stimulation by LPS, IB kinase (IKK) is activated and subsequently phosphorylates the IB␣ protein, which promotes degradation of IB␣ and leads to nuclear translocation of NF-B (16) . IKK also participates in the phosphorylation of NF-B p65 induced by LPS (37) . Transcriptional activity of NF-B is modulated by phosphorylation of NF-B p65 (29) . Activated NF-B p65 engages B enhancers and recruits the transcriptional coactivators CREB-binding protein (CBP)/p300 to trigger targetgene expression (41) .
Phosphatidylinositol 3-kinase (PI3K) and its downstream target, AKT, play important roles in cell survival and were implicated in LPS signaling. Akt is a regulator of NF-B activation induced by LPS (24) . Akt stimulates the transactivation ability of NF-B p65 via the involvement of IKK (19) . Recently, Dan et al. (6) reported that the mammalian target of rapamycin (mTOR) interacts with IKK and is involved in Akt-dependent regulation of NF-B. mTOR is a serine/threonine kinase downstream of PI3K/3-phosphoinositide-dependent kinase (PDK1)/Akt signaling and regulates transcription and translation of genes that control cell growth (38) . Rapamycin is a specific mTOR inhibitor and is clinically used as an immunosuppressant. Rapamycin was reported to diminish TLR4-mediated nuclear translocation of NF-B in colon cancer cells (32) . Inhibition of mTOR represses LPS-induced production of inflammatory cytokines and phosphorylation of NF-B in neutrophils, as well as the development and severity of acute lung injury (18) . This finding suggests that the Akt/ mTOR/IKK signaling cascade plays an important role in activation of NF-B.
Glutamine (GLN), circulating levels of which range 0.5ϳ0.7 mM, is the most abundant free amino acid in the bloodstream (7, 23) . Although GLN is considered to be a nonessential amino acid, several studies (36) demonstrated that GLN has immunomodulating properties during catabolic stress in which GLN levels in cells and plasma decline rapidly. GLN is an important fuel source for diverse cell types, especially epithelial and immune cells (1, 9) . The lungs are an important organ for GLN homeostasis. GLN is released from the lungs in the early stage of endotoxin-injured rats and sepsis patients to maintain amino acid pools in the body. However, the outflow of GLN from the lungs tends to diminish in patients with adult respiratory distress syndrome, which may be caused by increased consumption by injured lung cells (2) . Growing evidence reveals that GLN attenuates lung injury by inhibition of NF-B activation during sepsis (30) . Nuclear translocation and the DNA-binding activity of NF-B are suppressed by GLN administration (14, 31) .
Recent studies indicated that GLN modulates cell viability through the PI3K/Akt pathway. Deprivation of GLN leads to increased phosphorylation of Akt, and levels of activated Akt are decreased by supplemental GLN in intestinal epithelial cells (15) . Also, GLN was found to participate in activation of mTOR. GLN decreases phosphorylation of mTOR at physiologic concentrations normally found in plasma (28) . However, the modulatory role of GLN on the inflammatory signaling cascade is not clear, and whether GLN administration modulates phosphorylation of NF-B in lung epithelial cells has not been investigated. Since PI3K/Akt signaling is upstream of mTOR, we hypothesized that GLN modulates LPS-induced NF-B activation via the PI3K/Akt/mTOR pathway in lung epithelial cells. In this study, we administered GLN levels ranging from physiological to pharmacologic concentrations to investigate the effects of different GLN concentrations on inflammatory signaling cascades in lung epithelial cells.
BEAS-2B is the most commonly used human bronchial epithelial cell line, which is phenotypically similar to primary bronchial epithelium. Thus we used BEAS-2B in submerged culture to perform this study. To understand whether cells cultured at air-liquid interface (ALI) act through the same response pathways as cells in submerged culture, BEAS-2B cells cultured under ALI condition were also performed. In addition, primary mouse tracheal epithelial cells (MTEC) were used to examine whether the inflammatory response to LPS stimulation was identical to cell line.
MATERIALS AND METHODS

Culture of BEAS-2B cells.
The BEAS-2B cell line, derived from human bronchial epithelium transformed by the hybrid 12-SV40 adenovirus, was obtained from American Type Culture Collection (Manassas, VA). The cells were maintained in DMEM/F-12 medium (Sigma, St. Louis, MO) containing 10% FBS, 10 g/ml gentamicin, 2.5 mM GLN, and 15 mM HEPES at 37°C in a humidified 5% CO 2 incubator. BEAS-2B cells were cultured in 75-cm 2 tissue culture flasks and used for the experimental assay at passage numbers 52ϳ62. BEAS-2B cells under ALI condition were cultured according to a protocol of McGovern et al. (22) . Briefly, BEAS-2B cells were seeded (1 ϫ 10 5 cells/insert) onto 30-mm Millicell inserts (0.4 M pore size; Millipore, Billerica, MA), and the inserts were placed in sixwell plates. Cells were incubated with medium mentioned above filling apical and basolateral chambers for 4 days. On the fifth day, medium (DMEM/F-12 medium containing 5% FBS, 10 g/ml gentamicin, 2.5 mM GLN, and 15 mM HEPES) was added to the basolateral chambers and the medium in apical chambers was removed to establish an ALI. Cells were cultured for a further 7 days, and media were changed daily.
Primary culture of MTEC. MTEC from C57BL/6 mice were isolated and cultured according to a protocol of You et al. (39) . For cells in submerged culture, MTEC were seeded into type 1 rat-tail collagen-coated 24-well plates at a density of 1.5 ϫ 10 5 cells /well and were incubated with proliferation medium in 5% CO 2 at 37°C. Proliferation medium is DMEM/F-12 containing 5% FBS, 15 mM HEPES, 2.5 mM GLN, 50 g/ml gentamicin, and 0.1 g/ml Fungizone and supplemented with 0.1 M retinoic acid, 10 g/ml insulin, 25 ng/ml EGF (BD Bioscience, San Jose, CA ), 60 g/ml bovine pituitary extract (BD Bioscience), and 5 g/ml transferrin. Supplements were purchased from Sigma (St. Louis, MO) unless indicated. For cells in ALI culture, MTEC were seeded into type 1 rat-tail collagen-coated 12-mm Millicell inserts (0.4-M pore size, Millipore) at a density of 6 ϫ 10 4 cells /insert, and the inserts were placed in 24-well plates. Cells were incubated with proliferation medium filling apical and basolateral chambers for 10 -12 days. After achieving confluence, the apical medium was removed and differentiation medium was added to the basolateral chambers. Differentiation medium is DMEM/F-12 containing 2% NuSerum (BD Bioscience), 15 mM HEPES, 2.5 mM GLN, 50 g/ml gentamicin, and 0.1 g/ml Fungizone and supplemented with 0.1 M retinoic acid. Cells were cultured under ALI condition for 14 days, and media were changed every other day.
LPS For BEAS-2B cells in ALI culture, cells were subjected to 1 g/ml LPS stimulation from basolateral side in medium containing different concentrations of GLN. After 24 h of stimulation, 400 l of PBS were added to apical side to collect samples from the apical chamber, and media in basolateral chambers were also collected for measurement of interleukin (IL)-8 by ELISA. Whole cell lysates and total RNA were also prepared for analysis of immunoblotting and real-time PCR.
For MTEC in submerged culture, cells were placed in proliferation medium containing different concentrations of GLN with 1 g/ml LPS for 24 h after achieving confluence. Cell viability was measured, and media were collected for further analysis of keratinocyte-derived chemokine (KC) production. KC is a murine CXC chemokine, which is a functional homologue of IL-8 and a structural homologue of growth-related protein (GRO)-1. For MTEC in ALI culture, cells were subjected to 1 g/ml LPS stimulation from basolateral side in differentiation medium containing different concentrations of GLN for 24 h. After stimulation, 100 l of PBS was added to apical side to collect samples from the apical chamber, and media in basolateral chambers were also collected for measurement of KC by ELISA. Cells viability was also analyzed. At least three independent experiments were performed for each assay.
MTT assay. Cell viability was analyzed using the MTT assay. BEAS-2B cells in submerged cultured were seeded into 96-well plates (2,500 cells/well), incubated overnight, and then treated with different concentrations of GLN in the presence of LPS. Control cells received 2.5 mM GLN without LPS stimulation. After 24 h of treatment, cells were incubated in medium containing 0.5 mg/ml MTT (Sigma) at 37°C for 2 h. MTT was reduced into a water-insoluble formazan product by mitochondria of viable cells. Reduced MTT was solubilized in DMSO to measure the absorbance at 570 nM using a microplate reader.
Immunoblotting. Cells were washed with ice-cold PBS and scraped in lysis buffer (50 mM Tris pH 7.4, 1% SDS, and 10 mM EDTA) containing a protease inhibitor cocktail (Sigma) and phosphatase inhibitors (1 mM ␤-glycerophosphate, 10 mM NaF, 1 mM Na3VO4, and 1 mM sodium pyrophosphate) to prepare whole cell lysates. For preparation of cytoplasmic and nuclear extracts, NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific, Asheville, NC) were used according to manufacturer's instructions. Protein concentrations were determined by the Bradford protein assay reagent kit (Bio-Rad, Richmond, CA). Samples were solubilized and reduced in Laemmli sample buffer before electrophoresis. An equal amount of protein (10 -30 g) was separated by 4%ϳ12% SDS-PAGE, depending on the size of the proteins to be observed, and electrotransferred to PVDF membranes in a wet-transfer apparatus. Membranes were blocked with 5% nonfat milk in TBS for 1 h and then incubated with antibodies overnight at 4°C. Polyclonal rabbit antibodies against phospho-PDK1 Ser241 (3061), phospho-Akt Thr308 (9275), phospho-mTOR Ser2448 (2971), phospho-IKK␣ Ser180/IKK␤ Ser181 (2681), and phospho-NF-B p65 Ser536 (3033) were purchased from Cell Signaling (Danvers, MA). Polyclonal rabbit antibodies against NF-B p65 (06 -418) and IB␣ (07-1483) were purchased from Millipore (Temecula, CA). A monoclonal mouse antibody against histone H1 (SC-8030 and SC-10806) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal mouse antibodies against ␤-actin (A5441) and ␣-tubulin (T6074) were purchased from Sigma. Membranes were washed three times with TBS-Tween (TBS-T) and incubated with horseradish peroxidase-conjugated species-specific antibodies for 1 h. After being washed three times in TBS-T over 30 min, blots were developed with enhanced chemiluminescence reagents (PerkinElmer Life Sciences, Waltham, MA) and exposed to X-ray films. The relative intensity was measured to quantify the protein level using Image-Pro Plus software (Media Cybernetics, Bethesda, MD). All blots were normalized against internal controls to adjust the amount of proteins loaded.
RNA extraction and real-time PCR. Total RNA was extracted using the Trizol reagent (Invitrogen, Carlsbad, CA). RNA (1 g) was reverse transcribed using oligo(dT) 18 primers with a complementary (c)DNA synthesis kit (Fermentas, Glen Burnie, MD). A real-time RT-PCR was carried out in optical 96-well plates on an ABI 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA). Primers for IL-8, GRO-1, tumor necrosis factor (TNF)-␣, IL-1␤, and ␤-actin are listed in Table 1 . The expression of each gene was assayed in triplicate in a total volume of 25 l containing 1ϫ SYBR green master mix reagent (Applied Biosystems), 200 nM of each primer, and 50 ng of cDNA. Amplification was performed using the thermocycling protocol recommended by the PCR system (50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min). No-template controls and a melting curve analysis were used to confirm the specificity of the real-time PCR. Multiples of change of mRNA were calculated by the equation 2
Ϫ⌬⌬Ct (⌬Ct indicates the difference of threshold cycles between the test gene and ␤-actin, and ⌬⌬Ct indicates the difference of ⌬Ct between the stimulated and nonstimulated control groups).
Coimmunoprecipitation. Nuclear extracts were prepared using NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific). Nuclear extracts (50 g) were suspended in 500 l TBS-T, and a 10-l aliquot was retained as the input fraction. Precleared nuclear extracts were incubated with 2 g of an anti-NF-B p65 antibody (SC-109; Santa Cruz Biotechnology) and protein A magnetic beads (Millipore) overnight at 4°C with rotation. Immunoprecipitates were washed with TBS-T and resuspended in 2ϫ reducing loading buffer. Immunoprecipitated and input proteins were subjected to SDS-PAGE followed by immunoblotting with an anti-p300 antibody (SC-32244; Santa Cruz Biotechnology) or anti-NF-B p65 antibody, respectively.
Chromatin immunoprecipitation. The chromatin immunoprecipitation (ChIP) assay was used to monitor the recruitment of NF-B to the IL-8 gene promoter in BEAS-2B cells cultured under submerged condition, using a Megna ChIP A kit (Millipore). Briefly, cells were treated with formaldehyde to crosslink protein-DNA complexes and were collected to isolate nuclear extracts. After shearing the DNA by sonication, nuclear extracts were cleared by centrifugation at 15,000 g at 4°C for 10 min. Equal volumes of supernatant from each sample were removed, and dilute buffer containing protease inhibitor was added to a final volume to 500 l. An aliquot (5 l) was retained as the input fraction. The remaining chromatin preparation was incubated with 3 g of an anti-NF-B p65 antibody (SC-109; Santa Cruz Biotechnology) and protein A magnetic beads overnight at 4°C with rotation. After elution and reversal of crosslinking, DNA fragments were purified using spin columns provided in the kit. A real-time PCR was performed with input and immunoprecipitated DNA using IL-8 promoter-specific primers as described above. Primers for the IL-8 promoter are listed in Table 1 .
Luciferase reporter gene assay. NF-B promoter activity was determined by a Ready-To-Glow secreted luciferase reporter system (Clontech, Mountain View, CA), and ␤-galactosidase activity was used to normalize the transfection efficiency measured by a luminescent ␤-galactosidase detection kit (Clontech). BEAS-2B cells in submerged culture were grown to 80% confluence in 24-well plates and then cotransfected with the pNF-kB-MetLuc vector (2 g/ml) and ␤-galactosidase-control plasmid (0.4 g/ml) using the TurboFect transfection reagent (Fermentas). The transfection medium was removed 4 h later, and cells were cultured in complete medium to allow them to recover before treatment with different concentrations of GLN in the presence of LPS for 24 h. The medium and cell lysate were collected to evaluate the secreted luciferase and ␤-galactosidase activities with a plate luminometer according to the manufacturer's instructions.
ELISA. IL-8 and KC levels in the culture media were measured by ELISA kits (R&D Systems, Minneapolis, MN). Antibodies specific for IL-8 or KC were coated onto the wells of microtiter strips provided. Procedures followed the manufacturer's instructions.
Statistical analysis. All data are shown as the means Ϯ SD. All statistical analyses were performed with GraphPad Prism 5 software (GraphPad Software, La Jolla, CA). Data were analyzed by an ANOVA with Tukey's post hoc test. A P value of Ͻ0.05 was considered significantly different.
RESULTS
Administration of GLN improves cell viability subjected to LPS stimulation.
To determine whether GLN affects the cell viability of LPS-stimulated bronchial epithelial cells, BEAS-2B cells were incubated with varying concentration of GLN under submerged condition. The concentration of GLN ranged from a physiologic concentration in plasma (0.5 mM) to a pharmacologic concentration (2.5 mM). The percentage of viable cells was lowest in the absence of GLN administration (86.92 Ϯ 1.81%). When the concentration of GLN was raised to 0.5 mM, (Fig. 1A) and NF-B nuclear translocation (Fig. 1, B and C) were detected by immunoblotting. GLN deprivation alone did not cause NF-B activation. In the presence of LPS stimulation, GLN deprivation induced NF-B signaling (Fig.  1A) and increased NF-B translocation into nucleus (Fig. 1C) . NF-B signaling and NF-B translocation into nucleus were suppressed in LPS-stimulated cells cultured with 2.5 mM GLN, which was equivalent to the levels of cells cultured with 2.5 mM GLN alone. To understand the influences of different concentrations of GLN on NF-B signaling, BEAS-2B cells were incubated with 0, 0.5, 1, and 2.5 mM of GLN. Because the total expression levels of proteins analyzed were not affected by treatments with different concentrations of GLN (data not shown), the phosphorylated proteins were normalized by actin as the internal control. Both PDK1/Akt/mTOR (Fig. 2 , A-C) and IKK␤/NF-B (Fig. 2, D and E) pathways were significantly upregulated in the absence of GLN, which were reduced by GLN administration. Treatment with 0.5 mM GLN, which is close to a physiologic concentration, showed the most potent inhibition among treatments with supplemental GLN. PDK1 is downstream of PI3K, indicating that GLN may be involved in PI3K/Akt-mediated mTOR signaling to regulate NF-B activation via IKK in BEAS-2B cells.
GLN reduces activation of NF-B induced by LPS. Since nuclear translocation of the NF-B p65 subunit is required for NF-B activation, cytosolic and nuclear NF-B p65 protein levels were analyzed by immunoblotting to investigate the effects of GLN on NF-B activation. In the presence of LPS without GLN supplementation, the cytosolic NF-B p65 pool decreased (Fig. 3A) , and the nuclear NF-B p65 protein level effectively increased (Fig. 3B) , which is an indication of the nuclear translocation of NF-B p65. A reduction in the cytosolic IB␣ protein level was also observed in the absence of GLN with LPS stimulation (Fig. 3A) . Administration of GLN increased the cytosolic NF-B p65 and IB␣ protein pools in dose-dependent manners (Fig. 3A) . Treatment with supplemental GLN decreased the NF-B p65 protein level in the nuclear fraction despite a lack of a dose-dependent effect (Fig. 3B) .
GLN repressed expressions of NF-B target genes and transcriptional activity of NF-B.
Several NF-B target genes were analyzed using a real-time PCR to evaluate the effects of GLN on LPS-induced CXC chemokine and cytokine gene expressions. As shown in Fig. 4A , mRNAs of CXC chemokines (IL-8 and GRO-1) and inflammatory cytokines (TNF-␣ and IL-1␤) were significantly induced by LPS stimulation. Treatment without GLN dramatically increased mRNA expressions of NF-B-dependent genes and showed the maximal induction of IL-8 mRNA expression. Since GLN modulates the expression of NF-B target genes activated by LPS, coimmunoprecipitation and a ChIP assay were performed to determine whether GLN contributes to the transcriptional activity of NF-B. Treatments with supplemental GLN decreased the association of NF-B p65 with p300, a coactivator of p65 (Fig.  4B) . The binding activity of NF-B p65 to the IL-8 promoter region was also repressed in the presence of GLN (Fig. 4C) .
Effects of GLN on NF-B-dependent luciferase activity and IL-8 production induced by LPS.
To investigate the effects of GLN on NF-B-dependent promoter activity, BEAS-2B cells were transfected with a luciferase-expressing reporter plasmid containing enhancer elements of NF-B. As shown in Fig. 5A , NF-B-dependent luciferase activity was upregulated in the absence of GLN and declined with administration of GLN. Treatment with 0.5 mM GLN showed the best inhibitory ability among treatments with supplemental GLN. Production of LPS-induced IL-8 was highest in treatment without GLN, whereas supplemental GLN decreased the concentration of IL-8 in culture medium (Fig. 5B) . The IL-8 concentration was lowest in treatment with 0.5 mM GLN.
Implication of the PI3K/Akt/mTOR pathway in GLN modulation of NF-B. GLN repressed LPS-induced NF-B activation, which may have been caused by inhibition of PI3K/Akt/ mTOR signaling. To determine the involvement of PI3K and mTOR, BEAS-2B cells were cultured in the absence of supplemental GLN and, respectively, treated with rapamycin or LY294002 for 24 h. Rapamycin suppressed mTOR signaling, whereas LY294002 inhibited PI3K activation, which may be involved in the phosphorylation of PDK1. Treatment in the absence of supplemental GLN increased the phosphorylation and nuclear translocation of NF-B p65, as well as NF-Bdependent promoter activity induced by LPS (Fig. 6, A-C) . GLN supplementation decreased the phosphorylation of NF-B p65 and translocation of NF-B p65 into nuclei and NF-B-dependent luciferase activity. Both rapamycin and LY294002 reduced activation of NF-B under GLN-depleted treatment with LPS stimulation, supporting PI3K/Akt/mTOR signaling being involved in modulating the effect of GLN on LPS-induced NF-B activation. Although the suppression of phosphorylated NF-B p65 in supplemental GLN group was not as obvious as in rapamycin and LY294002-treated groups, the inhibitory ability of NF-B nuclear translocation in supplemental GLN group was equivalent to the rapamycin and LY294002-treated groups.
BEAS-2B cells cultured under ALI condition. Among the various GLN concentrations, IL-8 levels induced by LPS in both apical (Fig. 7A ) and basolateral chambers (Fig. 7B) were higher in treatments with 1 and 2.5 mM GLN. There were no significant differences between 0 and 0.5 mM GLN. However, treatment in the absence of GLN showed the maximal induction of IL-8 and GRO-1mRNA expression induced by LPS stimulation in BEAS-2B cells (Fig. 7C) . GLN deprivation alone caused partial NF-B activation. In the presence of LPS stimulation, GLN deprivation induced NF-B signaling greatly, which was suppressed in cells cultured with 2.5 mM GLN (Fig. 7D) . In the results of MTT assay, the percentage of viable cells was lowest in the absence of GLN administration (78.36 Ϯ 5.01%). When the concentration of GLN was raised to 0.5 mM, cell viability significantly increased and showed no significant difference from the nonstimulated control (97.91 Ϯ 
3.40%). The big difference on viability between cells cultured in GLN deprivation and with GLN administration at ALI was also observed in MTEC (data not shown).
Effects of GLN on KC production in MTEC. The production of KC was not upregulated with 0 mM GLN at ALI culture no matter in apical chamber (Fig. 8A ) or in basolateral chamber (Fig. 8B) . Under submerged conditions, the production of LPS-induced KC was highest in GLN deprivation, whereas supplemental GLN decreased the concentration of KC in culture medium (Fig. 8C) . The KC concentration was lowest in treatment with 0.5 mM GLN, which is consistent with the changes of IL-8 in BEAS-2B cell line.
DISCUSSION
In this study, we investigated the potential mechanism of GLN in modulating LPS-induced NF-B activation in lung epithelial cells. Our results show that compared with GLN deprivation, administration of GLN improved cell viability subjected to LPS stimulation, inhibited NF-B activation through the PI3K/Akt/mTOR pathway, and suppressed NF-B DNA-binding activity, which led to repression of the expression of NF-B-targeted genes.
LPS is a potent activator of NF-B through activation of the IKK complex. The IKK complex is composed of two catalytic subunits (IKK␣ and IKK␤) and a regulatory subunit (IKK␥). IKK␤ is a key regulator of the canonical NF-B pathway that is turned on by proinflammatory stimuli, and the NF-B p65 subunit is involved in the stimulated response. It was revealed that nuclear translocation of NF-B is insufficient to promote maximal activation of NF-B (4). Phosphorylation of the NF-B p65 subunit plays an important role in the NF-Bdependent transcriptional ability (29, 42) . LPS stimulation upregulates the phosphorylation of NF-B p65 on serine 536 within the transactivation domain, which is IKK␤ dependent A: mRNAs of NF-B target genes were analyzed by a real-time PCR. Quantitation of multiples of mRNA change was calculated by the comparative CT method. Cells incubated with 2.5 mM GLN without LPS administration were used as a nonstimulated control (NC). B: effect of GLN on the association between p65 and p300. NF-B p65 immunoprecipitated (IP) and p300 bound to NF-B p65 were detected by immunoblotting. C: recruitment of NF-B p65 to IL-8 promoters was analyzed by a chromatin immunoprecipitation assay. Cells were incubated with 2.5 mM GLN in the absence of LPS, or incubated with different GLN concentrations (0 and 2.5 mM) with LPS stimulation. Quantitation of IL-8 promoter mRNA was normalized to input chromatin and expressed as the %input. *P Ͻ 0.05, significantly different compared with the NC and treatments with different GLN concentrations. A: NF-B-dependent transcription activity was measured by a reporter gene assay. Luciferase activity of nonstimulated control cells was set to 1, and relative ratios of treatment with different GLN concentrations in the presence of LPS were calculated. Transfection efficiency was normalized to ␤-galactosidase activity. B: concentration of IL-8 in culture medium was detected by an ELISA. *P Ͻ 0.05, significantly different compared with treatments with different GLN concentrations.
† P Ͻ 0.05, significantly different compared with treatments with 1 and 2.5 mM GLN. # P Ͻ 0.05, significantly different compared with treatments with LPS stimulation. (37) . The phosphorylated NF-B p65 subunit increases assembly with p300, thus enhancing the transcriptional ability of NF-B (5).
PI3K/Akt pathway signaling is implicated in cell survival. Phosphorylation of Akt on both threonine 308 and serine 473 is induced by LPS stimulation, and blockade of PI3K attenuates this site-specific phosphorylation (10, 21) . Studies on regulation of the PI3K/Akt pathway in NF-B-targeted gene expressions are controversial. Both positive regulation and negative regulation of NF-B's action by the PI3K/Akt signaling pathway were reported. Previous studies (19, 20) demonstrated that Akt stimulates the activation potential of NF-B through IKK to provide a cell survival function in murine NIH 3T3 fibroblasts. However, inhibition of PI3K/Akt signaling in human monocytic THP-1 cells enhancing NF-B activation was also reported (10, 40) . Discrepancies among studies may have resulted from different cell types and treatments in the respective experiment. The results of this study support the positive description of the PI3K/Akt signaling pathway on NF-B's action, in that LPS stimulation in the absence of supplemental GLN increased phosphorylation of NF-B p65 on serine 536 and the nuclear translocation of NF-B in lung epithelial cells by upregulating the PDK1/Akt and IKK␤ signaling cascades. These findings are consistent with a previous study done in intestinal epithelial cells that GLN deprivation increases LPS-induced IL-8 production through IB/NF-B (17) and activates the PI3K/Akt pathway, thus acting as a protective mechanism to limit cell death (15) .
Recent studies (12, 34) identified another downstream target of the PI3K/Akt pathway, mTOR, which is involved in regulating cell survival and immune responses. Upon activation of PI3K/Akt signaling, Akt phosphorylates mTOR and promotes Fig. 6 . Involvement of the PDK1/mTOR pathway in GLN modulation of NF-B. Cells were incubated with GLN (2.5 mM), rapamycin (100 nM), or LY294002 (10 M) with LPS stimulation for 24 h in submerged culture. Each treatment group received an equal amount of DMSO (final concentration, 0.1%). A: immunoblotting was performed using whole cell lysates to detect phosphorylation of NF-B p65. B: cytoplasmic and nuclear extracts were analyzed by immunoblotting to determine nuclear translocation of NF-B. C: a reporter gene assay was used to measure the NF-B-dependent transcription activity. *P Ͻ 0.05, significantly different compared with all treatments.
† P Ͻ 0.05, significantly different compared among treatments with supplemental GLN. IKK-dependent activation of NF-B (6). Recent studies (18, 34) demonstrated regulation of the LPS-induced inflammatory response by mTOR. Lorne et al. (18) indicated that mTOR is essential for LPS-induced NF-B activation of neutrophils. Inhibition of mTOR decreases proinflammatory cytokines produced by neutrophils and inhibits phosphorylation of NF-B p65, leading to attenuation of the severity of lung injury. In the present study, Akt/mTOR signaling was activated in GLN deprivation with LPS stimulation, which was suppressed by GLN administration. Activation of Akt/mTOR signaling led to increases in phosphorylated NF-B p65 levels and NF-B translocation, which were confirmed by blockage of PI3K and mTOR signaling in GLN-deprived cells. These results suggest that GLN modulates LPS-induced NF-B activation through the Akt/mTOR pathway.
We found that compared with physiological levels of GLN (0.5 mM), high concentrations of GLN (1 and 2.5 mM) produced higher Akt/mTOR/IKK␤ signaling cascade expressions. Activation of Akt downstream targets with high GLN concentrations might have been due to PI3K/Akt survival signaling, because a higher cell viability was also observed in these groups. However, nuclear translocation of NF-B p65 was not consistent with this result, which showed no differences among the GLN-supplemented groups. Nuclear translocation of NF-B is controlled by phosphorylation and degradation of IB␣. Previous studies (13) indicated that GLN administration decreased the ubiquitin-IB␣ complex to prevent IB␣ from degradation. Our results demonstrated that cytosolic IB␣ increased with supplemental GLN, which retained NF-B in the cytosol. This may be explained by the inhibition of GLN in the ubiquitin-dependent degradation of IB␣.
In this study, we demonstrated that mTOR signaling was upregulated in GLN deprivation with LPS stimulation, which was suppressed by GLN supplementation. Our findings are consistent with a study performed by Sakiyama el al. (28) , who also found that the phosphorylated mTOR decreased in intestinal epithelial cells cultured with physiologic concentrations of GLN compared with GLN deprivation. A recent study (3) found that GLN modulates protein synthesis via both mTOR and general controller nondepressible 2 kinase (GCN2) pathways. Our results indicated that NF-B-dependent luciferase activity and IL-8 levels increased in the high-GLN-concentration groups compared with 0.5 mM GLN groups. However, the transcriptional abilities of NF-B and IL-8 mRNA expressions did not differ among different supplemental GLN groups. These findings suggested the possibility of posttranscriptional or translational regulation of GLN. Because higher levels of phosphorylated mTOR were also found in 1 and 2.5 mM GLN groups compared with the 0.5 mM GLN group, we hypothesized that mTOR activation may contribute to GLN's modulatory effects on protein synthesis in this study. mTOR is a central regulator of cell growth in response to environmental factors such as nutrient availability, hypoxia, DNA damage, and osmotic stress (27) . mTOR controls the translation machinery through modulation of p70 ribosomal S6 kinase (p70S6K) and eIF-4E-binding protein (4E-BP1). Activation of mTOR leads to phosphorylation of p70S6K and 4EBP1, which increases protein translation (33) . A previous study (26) indicated that GLN is required for activation of mTOR, which synergizes with essential amino acids. GLN is shuttled out of cells in exchange for essential amino acids, which directly activate mTOR. The maximal activation of mTOR occurred with 1 mM GLN (26) , which is comparable to our results. Although IL-8 production was higher when treated with high concentrations of GLN (1 and 2.5 mM), these GLN concentrations maintained high cell viability. Previous animal studies (25, 35) showed that GLN attenuates intravenous LPS-induced lung injury. GLN administration attenuates lung injury by inhibiting NF-B activation during sepsis (14, 30, 31) . Whether GLN administration modulates mTOR-mediated lung inflammation and thus decreases NF-B activation in an in vivo situation is not clear, and further studies are necessary to determine if this is the primary pathway in lung injury models.
In this study, we found that there were some differences between ALI and submerged cultures. IL-8 levels were highest Fig. 8 . Effects of GLN on kerotinocyte-derived chemokine (KC) production in mouse tracheal epithelial cells cultured under ALI and submerged conditions. A: concentration of KC in apical chamber under ALI condition. B: concentration of KC in basolateral chamber under ALI condition. C: concentration of KC in medium under submerged culture. Cells incubated with 2.5 mM GLN without LPS administration were used as a nonstimulated control. *P Ͻ 0.05, significantly different compared with treatments with different GLN concentrations.
† P Ͻ 0.05, significantly different compared with treatments with 1 and 2.5 mM GLN.
# P Ͻ 0.05, significantly different compared with treatments with LPS stimulation.
in BEAS-2B cells cultured in the absence of GLN under submerged culture, whereas the production of IL-8 did not upregulate in BEAS-2B cells cultured with 0 mM GLN at ALI even though the maximal induction of IL-8 mRNA was observed. The similar phenomenon was also found in the KC production of MTEC. However, our results confirmed that the modulatory effects of GLN in LPS-induced NF-B activation via the Akt/mTOR pathway done with BEAS-2B under submerged condition were also observed at ALI. Under ALI condition, both the MTEC and BEAS-2B cells had the similar LPS-induced CXC-chemokine response indicating different culture condition is responsible for the chemokine response at 0 mM GLN. Because there was a 20% difference in viability between cells cultured under ALI condition in GLN deprivation and with GLN administration, the inconsistency between CXC-chemokine mRNA and protein levels can be at least partly explained by cell viability.
In summary, the present study showed that GLN administration decreased LPS-induced NF-B activation through inhibition of the PI3K/Akt/mTOR pathway in lung epithelial cells. Also, expressions of NF-B-targeted genes were suppressed with treatment with supplemental GLN, which is consistent with the reduction of NF-B associated with p300 and NF-Bbinding activities. Among the various GLN concentrations, 0.5 mM GLN showed the greatest inhibitory effects on the Akt/ mTOR/IKK␤/NF-B signaling cascade. Although the overall effect of glutamine is more pronounced in submerged culture than it is at ALI, our study provides a potential mechanism for GLN of modulating LPS-induced NF-B activation in lung epithelial cells and implies that maintaining a physiological concentration of GLN is essential to preventing LPS-induced lung inflammation.
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